Analysts expect The Procter & Gamble Company (NYSE:PG) to report $18.19 billion in sales for the current quarter, Zacks Investment Research reports. Six analysts have made estimates for The Procter & Gamble’s earnings, with the lowest sales estimate coming in at $17.73 billion and the highest estimate coming in at $18.52 billion. The Procter & Gamble reported sales of $17.70 billion during the same quarter last year, which indicates a positive year over year growth rate of 2.8%. The firm is expected to issue its next earnings results on Thursday, July 29th.
According to Zacks, analysts expect that The Procter & Gamble will report full year sales of $75.38 billion for the current fiscal year, with estimates ranging from $74.91 billion to $75.69 billion. For the next fiscal year, analysts forecast that the company will post sales of $77.72 billion, with estimates ranging from $76.54 billion to $78.68 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow The Procter & Gamble.
The Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Monday, April 19th. The company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.07. The company had revenue of $18.10 billion during the quarter, compared to analyst estimates of $18 billion. The Procter & Gamble had a net margin of 18.92% and a return on equity of 30.69%. The Procter & Gamble’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the firm posted $1.17 EPS.
Shares of NYSE:PG traded down $0.46 during trading on Thursday, hitting $134.54. 9,605,546 shares of the stock traded hands, compared to its average volume of 8,296,208. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.50. The company has a market cap of $329.39 billion, a price-to-earnings ratio of 25.72, a P/E/G ratio of 3.25 and a beta of 0.38. The company has a fifty day moving average price of $134.03 and a two-hundred day moving average price of $134.74. The Procter & Gamble has a 52-week low of $111.25 and a 52-week high of $146.92.
The firm also recently announced a quarterly dividend, which will be paid on Monday, May 17th. Shareholders of record on Friday, April 23rd will be paid a dividend of $0.8698 per share. This represents a $3.48 annualized dividend and a yield of 2.59%. The ex-dividend date is Thursday, April 22nd. This is a boost from The Procter & Gamble’s previous quarterly dividend of $0.79. The Procter & Gamble’s payout ratio is 67.97%.
In other news, Director Nelson Peltz sold 408,880 shares of the business’s stock in a transaction dated Wednesday, February 3rd. The shares were sold at an average price of $128.71, for a total transaction of $52,626,944.80. Following the transaction, the director now owns 5,357 shares of the company’s stock, valued at approximately $689,499.47. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Steven D. Bishop sold 3,173 shares of the business’s stock in a transaction dated Friday, February 26th. The shares were sold at an average price of $125.77, for a total transaction of $399,068.21. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 560,215 shares of company stock worth $72,179,449. 0.70% of the stock is currently owned by corporate insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Morgan Stanley raised its holdings in The Procter & Gamble by 6.5% in the 4th quarter. Morgan Stanley now owns 32,345,298 shares of the company’s stock valued at $4,500,525,000 after buying an additional 1,964,987 shares during the period. Norges Bank purchased a new stake in The Procter & Gamble during the fourth quarter worth about $3,679,005,000. Nuveen Asset Management LLC increased its stake in The Procter & Gamble by 8.2% during the fourth quarter. Nuveen Asset Management LLC now owns 16,571,944 shares of the company’s stock worth $2,305,820,000 after purchasing an additional 1,260,453 shares during the period. Janus Henderson Group PLC increased its stake in The Procter & Gamble by 0.7% during the fourth quarter. Janus Henderson Group PLC now owns 12,990,893 shares of the company’s stock worth $1,807,482,000 after purchasing an additional 85,934 shares during the period. Finally, Alliancebernstein L.P. increased its stake in The Procter & Gamble by 5.0% during the fourth quarter. Alliancebernstein L.P. now owns 12,812,531 shares of the company’s stock worth $1,782,736,000 after purchasing an additional 611,102 shares during the period. Hedge funds and other institutional investors own 63.05% of the company’s stock.
The Procter & Gamble Company Profile
The Procter & Gamble Company provides branded consumer packaged goods to consumers in North and Latin America, Europe, the Asia Pacific, Greater China, India, the Middle East, and Africa. It operates in five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care.
Read More: What are gap-down stocks?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for The Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.